Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10.
作者信息
Eggert Tobias, McGlynn Katherine A, Duffy Austin, Manns Michael Peter, Greten Tim F, Altekruse Sean F
机构信息
Gastrointestinal Malignancy Section, Medical Oncology Branch, National Cancer Institute, , Bethesda, Maryland, USA.
出版信息
Gut. 2013 Nov;62(11):1667-8. doi: 10.1136/gutjnl-2013-305164. Epub 2013 May 25.
Abstract
摘要
相似文献
1
Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10.2000 - 2010年美国纤维板层型肝细胞癌的流行病学
Gut. 2013 Nov;62(11):1667-8. doi: 10.1136/gutjnl-2013-305164. Epub 2013 May 25.
2
HCCR-1 for detecting small hepatocellular carcinoma latent in a cirrhotic liver: a prospective cohort study.用于检测肝硬化肝脏中潜伏的小肝细胞癌的HCCR-1：一项前瞻性队列研究。
Gut. 2012 Oct;61(10):1514-5. doi: 10.1136/gutjnl-2012-301994. Epub 2012 Jul 31.
3
A meta-analysis for percutaneous tumour ablation in patients with small hepatocellular carcinoma: highlighting combined strategy in the future.小肝细胞癌患者经皮肿瘤消融的荟萃分析：突出未来的联合策略
Gut. 2013 Mar;62(3):477-8. doi: 10.1136/gutjnl-2012-303584. Epub 2012 Sep 26.
4
Comparison of MRI with liver-specific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies.磁共振成像联合肝脏特异性对比剂与多排螺旋CT检测肝细胞癌的比较：15项直接比较研究的荟萃分析
Gut. 2013 Oct;62(10):1520-1. doi: 10.1136/gutjnl-2013-305231. Epub 2013 Aug 8.
5
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.前瞻性验证免疫组化 panel（磷脂酰糖蛋白 3、热休克蛋白 70 和谷氨酰胺合成酶）在肝活检中的诊断非常早期肝细胞癌的应用。
Gut. 2012 Oct;61(10):1481-7. doi: 10.1136/gutjnl-2011-301862. Epub 2012 Jan 27.
6
Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.由磷脂酰肌醇蛋白聚糖-3、热休克蛋白-70和谷氨酰胺合成酶组成的免疫组化检测组合在鉴别低级别肝细胞癌与肝细胞腺瘤中的应用。
Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):170-6. doi: 10.1097/PAI.0b013e31825d527f.
7
Early HCC: diagnosis and molecular markers.早期肝癌：诊断与分子标志物
J Gastroenterol. 2009;44 Suppl 19:108-11. doi: 10.1007/s00535-008-2245-y. Epub 2009 Jan 16.
8
Immunoexpression of Heat Shock Protein 70, Glypican 3, Glutamine Synthetase, and Beta-Catenin in Hepatocellular Carcinoma After Liver Transplantation: Association Between Positive Glypican 3 and Beta-Catenin With the Presence of Larger Nodules.肝移植后肝细胞癌中热休克蛋白70、磷脂酰肌醇蛋白聚糖3、谷氨酰胺合成酶和β-连环蛋白的免疫表达：磷脂酰肌醇蛋白聚糖3和β-连环蛋白阳性与较大结节存在之间的关联
Transplant Proc. 2017 May;49(4):858-862. doi: 10.1016/j.transproceed.2017.01.048.
9
Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.早期肝细胞癌组织学诊断的候选分子标志物
Intervirology. 2008;51 Suppl 1:42-5. doi: 10.1159/000122603. Epub 2008 Jun 10.
10
Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity.热休克蛋白70、谷氨酰胺合成酶和磷脂酰肌醇蛋白聚糖-3联合使用，对乙肝相关肝细胞癌具有较高的诊断特异性和敏感性。
Eur J Histochem. 2018 Jan 29;62(1):2859. doi: 10.4081/ejh.2018.2859.
引用本文的文献
1
Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver.肝纤维板层癌治疗的当前进展
J Hepatocell Carcinoma. 2023 May 15;10:745-752. doi: 10.2147/JHC.S406902. eCollection 2023.
2
Chemical, Molecular, and Single-nucleus Analysis Reveal Chondroitin Sulfate Proteoglycan Aberrancy in Fibrolamellar Carcinoma.化学、分子和单核分析揭示纤维板层癌中软骨素硫酸盐蛋白聚糖异常。
Cancer Res Commun. 2022 Jul 18;2(7):663-678. doi: 10.1158/2767-9764.CRC-21-0177. eCollection 2022 Jul.
3
Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event.纤维板层型肝细胞癌：一种罕见但不良的病症。
World J Gastrointest Oncol. 2022 Jun 15;14(6):1103-1114. doi: 10.4251/wjgo.v14.i6.1103.
4
Human liver organoids for disease modeling of fibrolamellar carcinoma.人肝类器官用于纤维板层样肝癌的疾病建模。
Stem Cell Reports. 2022 Aug 9;17(8):1874-1888. doi: 10.1016/j.stemcr.2022.06.003. Epub 2022 Jul 7.
5
Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients.建立并验证用于预测纤维板层型肝细胞癌患者肿瘤特异性生存的列线图模型。
Updates Surg. 2022 Oct;74(5):1589-1599. doi: 10.1007/s13304-022-01308-3. Epub 2022 Jun 17.
6
Multiomic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma.多组学分析 miRNA 介导的调控揭示了纤维板层样肝癌中涉及 miR-10b 的增殖轴。
JCI Insight. 2022 Jun 8;7(11):e154743. doi: 10.1172/jci.insight.154743.
7
Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical appraisal of current literature about imaging features of two rare liver cancers.肝上皮样血管内皮瘤和纤维板层型肝细胞癌的影像学表现：对当前关于两种罕见肝癌影像学特征文献的批判性评价
Transl Cancer Res. 2019 Apr;8(Suppl 3):S297-S310. doi: 10.21037/tcr.2018.11.33.
8
Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database.影响纤维板层型肝细胞癌患者总生存期的因素：监测、流行病学和最终结果数据库分析
Int J Gen Med. 2022 Jan 8;15:393-406. doi: 10.2147/IJGM.S338066. eCollection 2022.
9
Liver transplantation in malignant disease.恶性疾病中的肝移植
World J Clin Oncol. 2021 Aug 24;12(8):623-645. doi: 10.5306/wjco.v12.i8.623.
10
Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports.阿特珠单抗和贝伐单抗治疗纤维板层型肝细胞癌：两例病例报告
J Med Case Rep. 2021 Mar 16;15(1):132. doi: 10.1186/s13256-021-02695-8.
本文引用的文献
1
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.前瞻性验证免疫组化 panel（磷脂酰糖蛋白 3、热休克蛋白 70 和谷氨酰胺合成酶）在肝活检中的诊断非常早期肝细胞癌的应用。
Gut. 2012 Oct;61(10):1481-7. doi: 10.1136/gutjnl-2011-301862. Epub 2012 Jan 27.
2
Sorafenib in advanced hepatocellular carcinoma.索拉非尼用于晚期肝细胞癌
N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857.
3
Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.纤维板层癌的临床病理特征及生存情况：与伴或不伴肝硬化的传统肝细胞癌的比较
Mod Pathol. 2005 Nov;18(11):1417-23. doi: 10.1038/modpathol.3800449.
4
Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.纤维板层癌与肝细胞癌不同吗？一项基于美国人群的研究。
Hepatology. 2004 Mar;39(3):798-803. doi: 10.1002/hep.20096.
5
Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants.肝细胞癌的自然史，包括纤维板层癌和肝内胆管癌变体。
J Gastroenterol Hepatol. 2002 Apr;17(4):401-5. doi: 10.1046/j.1440-1746.2002.02734.x.
6
Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.肝纤维板层癌：一种具有独特临床病理特征的青少年及青年成人肿瘤。
Cancer. 1980 Jul 15;46(2):372-9. doi: 10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s.
7
Fibrolamellar hepatoma.纤维板层型肝癌
Am J Surg. 1985 Jan;149(1):113-9. doi: 10.1016/s0002-9610(85)80019-2.
Zotero 插件